指南与共识血液淋巴病理

2022年国际共识与WHO血液病理分类的导航:统一诊断语言的呼吁

Navigating the 2022 International Consensus and World Health Organization Classifications of Hematopathology: A Call for Unified Diagnostic Language.
指南 / 共识 · Arch Pathol Lab Med · 2025-01-01

该研究通过在线匿名调查(REDCap)了解美国血液肿瘤科医生和血液病理学家对2022年WHO第5版(WHO2022)与国际共识分类(ICC)的使用现状。共获得310份回复,仅10.7%单用2016 WHO指南,54%补充其他指南,14.9%单用WHO2022,1.9%单用ICC。超过90%认为两套指南造成临床诊断、管理、试验设计等领域的混淆,呼吁统一诊断语言。

要点

  • 仅10.7%的受访者单用2016 WHO指南,54%补充其他指南。
  • 超过90%认为两套指南造成临床诊断与管理混淆。
  • 指南选择与地区、实践环境或医院规模无关。

核心结论

  • 两套指南并存是医生困惑的来源,凸显统一诊断语言的需求。

研究设计与样本

  • 在线匿名调查(REDCap),通过邮件和社交媒体分享链接,共获得310份回复。

主要发现

  • 309名受访者中,33人(10.7%)单用2016 WHO指南,167人(54%)补充其他指南,46人(14.9%)单用WHO2022,6人(1.9%)单用ICC,17人(5.5%)不确定。
  • 指南选择与地区(P = .15)、实践环境(P = .86)或医院规模(P = .22)无关。
  • 超过90%的受访者认为两套指南是临床诊断、管理、试验设计等领域的混淆来源。

临床怎么用

  • 血液病理诊断中需注意2022年WHO与ICC分类的差异,避免因指南选择不同导致诊断不一致。
  • 临床管理及试验设计时应明确所依据的指南版本,必要时补充其他指南以减少混淆。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: In 2022, 2 distinct guidelines for the diagnosis of myeloid neoplasms became available: the 5th edition of the World Health Organization guideline (WHO2022) solely and the International Consensus Classification (ICC). Despite major overlap, there are important differences that can have important implications. OBJECTIVE.—: To explore the current opinions and diagnostic practices of hemato-oncologists and hematopathologists across the United States. DESIGN.—: An online anonymous survey was created using REDCap, and a secure link was shared via email to fellowship program leadership and via posts on social media. RESULTS.—: A total of 310 responses were obtained. Only 33 of 309 respondents (10.7%) reported using solely the 2016 World Health Organization guideline to make diagnoses, whereas 167 of 309 (54%) supplemented it with other guidelines. The rest were either not sure (17; 5.5%), used WHO2022 solely (46; 14.9%), or used ICC solely (6; 1.9%). The choice of guideline was not related to region (P = .15), practice setting (P = .86), or hospital size (P = .22). More than 90% reported having 2 distinct guidelines is a source of confusion in clinical diagnosis, management, trial design, and other areas. CONCLUSIONS.—: Overall, our study found that having 2 distinct guidelines could be a source of confusion for physicians and it highlights the need for a unified diagnostic language.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Zureigat H, Adcock B, Nurse DP, et al. Navigating the 2022 International Consensus and World Health Organization Classifications of Hematopathology: A Call for Unified Diagnostic Language. Arch Pathol Lab Med. 2025. PMID: 38952288. doi:10.5858/arpa.2024-0031-OA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。